Full Text View
Tabular View
No Study Results Posted
Related Studies
A Trial Using Molecular-Guided Therapy in Patients With Refractory or Recurrent Neuroblastoma
This study has been completed.
Study NCT01109238   Information provided by Van Andel Research Institute

First Received on April 21, 2010.   Last Updated on May 24, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Refractory Neuroblastoma
Relapsed Neuroblastoma
Additional conditions recognized in this trial
Neuroblastoma
More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neoplasms, Neuroepithelial
Neuroectodermal Tumors
Neuroectodermal Tumors, Primitive
Neuroectodermal Tumors, Primitive, Peripheral
Sponsors listed in this trial
Van Andel Research Institute


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services